Bristol Myers Squibb Company Una Corporación Del Estado De Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Company Una Corporación Del Estado De DelawarefiledCriticalBristol Myers Squibb Company Una Corporación Del Estado De Delaware
Priority to UY0001034907ApriorityCriticalpatent/UY34907A/en
Publication of UY34907ApublicationCriticalpatent/UY34907A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La presente descripción se refiere en general a compuestos antivirales y más específicamente, se re fiere a combinaciones de compuestos que pueden inhibir la función de la proteína NS5A codificada po r el virus de Hepatitis C (HCV), a composiciones que comprenden tales combinaciones y a métodos para inhibir la función de la proteína NS5A.The present description generally refers to antiviral compounds and more specifically, it refers to combinations of compounds that can inhibit the function of the NS5A protein encoded by the Hepatitis C virus (HCV), to compositions comprising such combinations and to methods to inhibit the function of the NS5A protein.
UY0001034907A2013-07-122013-07-12
INHIBITING COMPOUNDS OF THE FUNCTION OF THE NS5A PROTEIN OF HEPATITIS C VIRUS
UY34907A
(en)